Artificial intelligence and machine learning companies develop software, algorithms and computational platforms that analyse biological data, automate workflows and accelerate scientific discovery. These technologies are increasingly used across drug discovery, diagnostics, genomics and healthcare research.
This category includes companies working on:
Browse 243 UK AI and machine learning companies below.
AI-driven microRNA biomarker diagnostics for early veterinary disease detection
MI:RNA Diagnostics is a UK-based developer of a diagnostic platform combining microRNA biomarker panels with a proprietary artificial intelligence model to detect early-stage disease in animals. The company's flagship application targets cardiac disease in cats and dogs, with further research into Johne's disease…
AI-driven target identification and drug discovery from omics data
Intelligent OMICS is a biotechnology company applying artificial intelligence and machine learning to drug discovery and diagnostics. Its proprietary platform analyses transcriptomic, genomic, and proteomic datasets to identify novel biological targets and disease drivers. The company offers fee-for-service target…
Small molecule drug discovery platform focused on immuno-inflammation
C4X Discovery (C4XD) is a UK drug discovery company developing small molecule drug candidates using its proprietary computational and structural chemistry platform. It applies enhanced candidate molecule design and patient stratification capabilities to generate drug candidates across immuno-inflammatory disease…
ML-driven antibody discovery platform for solid tumour therapeutics
LabGenius Therapeutics is a company developing next-generation therapeutic antibodies using its closed-loop machine learning platform. The platform integrates AI, robotic automation and high-throughput experimentation to co-optimise multispecific antibodies across potency, selectivity and manufacturability…
Digital cognitive assessment and CNS clinical trial software platform
Cambridge Cognition provides digital cognitive assessment and clinical trial technology for central nervous system drug development. Its validated computerised tests measure memory, attention and executive function across conditions including Alzheimer's disease and schizophrenia. The company also offers electronic…
AI-powered immune profiling platform for precision medicine
IMU Biosciences is a biotechnology company coupling high-resolution, systems-level immune profiling with proprietary AI analytics to build a detailed atlas of the human immune system across health and disease. Its platform can identify and analyse over 2,000 immune cell subsets from blood samples, generating…
AI toxicology prediction platform reducing animal testing
Consone AI is a software company developing AI-driven toxicology prediction tools for the drug development process. Its platform uses machine learning algorithms trained on a curated database of over 80,000 chemical compounds to predict toxicological outcomes across multiple species, from preclinical models through to…
Point-of-care diagnostics and AI triage for cancer patients
52North is a medical technology company developing diagnostics and digital tools for urgent cancer care. Its lead programme is a point-of-care blood test designed to help chemotherapy patients assess their risk of neutropenic sepsis outside hospital, alongside an AI-supported app for triaging acute oncology symptoms.…
AI live cell imaging platform for stem cell therapy development
CellVoyant is a biotech developing AI-powered live cell imaging and process optimisation platforms for stem cell therapy development. The technology uses computer vision and neural network models to predict stem cell differentiation behaviour in real time, without destructive sampling, enabling earlier and more…
Stem cell platform for precision psychiatry and drug discovery
MeOmics Precision Medicine is a biotechnology company developing a precision psychiatry platform that combines genomics, phenomics, and stem cell-based cellular assays to generate biomarkers for severe mental illness. Patient-derived neurons, stimulated via multi-electrode array recording, produce electrophysiological…
AI-guided CRISPR platform developing precision-bred crop varieties
Phytoform Labs is a plant biotechnology company combining artificial intelligence and CRISPR-Cas gene editing to accelerate the development of novel crop traits. Its platform models sequence-to-function relationships across plant genomes to predict beneficial DNA variants, which are implemented as transgene-free…
Integrated bioprocessing platform for biologics development and manufacture
Biologic Technologies is a developer of intelligent bioprocessing platforms for biologics development and manufacturing. Its platform integrates complete biological workflows into a single automated device, combining precision fluid handling, in-line process analytics, and AI-driven optimisation. Application-specific…
AI-assisted bioactive ingredient discovery and laboratory formulation testing
HexisLab is a research and development company providing ingredient discovery, laboratory testing and formulation services for personal care and consumer health businesses. Its HexisPro.X platform uses computational screening to identify candidate bioactive compounds, peptides and sustainable ingredient alternatives.…
AI bioprocess operating system for cell and gene therapy manufacturing
Native Labs Ltd is a software company developing an AI-powered bioprocess operating system for cell and gene therapy manufacturing. The platform unifies heterogeneous manufacturing data, including bioreactor time series, multi-omics, and batch records, into standardised AI-ready datasets. Neural network models enable…
AI-enabled genomic and clinical data analysis for research
SökerData is a health data technology company developing AI-enabled tools for analysis of genomic and clinical datasets from underrepresented populations. Its platform helps life-science researchers explore biomarker associations across demographic groups and identify representation gaps in health data used for drug…
AI-designed antibody biologics adapting human therapeutics for companion animals
Antigenesis Biologics is a biotechnology company developing targeted biological treatments for companion animals, applying expertise in human antibody therapeutics to address a gap between human and veterinary healthcare innovation. The company uses AI and computational design approaches to develop antibody-based…
RBC derived nanoparticles for RNA delivery to brain and immune cells
Crane Biosciences is a biotechnology company developing a non-immunogenic RNA delivery platform based on nanoparticles derived from red blood cell membranes. By using the body's own cellular architecture as a delivery vehicle, the platform achieves substantially higher in vivo delivery efficiency to target tissues…
Software standardising experimental protocols for reproducibility and lab automation
Briefly Bio is a software company that helps scientists record experimental protocols in a clear, structured and consistent format. Its platform uses AI to identify gaps and errors in protocol descriptions and to validate and adapt protocols for specific lab automation systems. The company aims to improve experimental…
Semiconductor biosensors for blood-based cancer biomarker detection
ExoNostic is a diagnostic technology company developing semiconductor biosensors for cancer biomarker detection. Its investigational lab-on-a-chip platform is designed to identify molecular signatures in small blood samples, combining sensor-based measurements with computational interpretation. An Innovate UK-funded…
AI-driven enzyme engineering platform for pharmaceutical manufacturing
Imperagen is a biotechnology company developing an automated enzyme engineering platform that combines AI-powered protein design with synthetic biology and laboratory automation. The company engineers optimised biocatalysts for pharmaceutical manufacturing, enabling greener and more efficient production of complex…